Orange Book product · Generic (ANDA)
IVERMECTIN
IVERMECTIN
At a glance
Sep 13, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 13, 2019
6 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
IVERMECTIN
Strength
1%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 210019
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IVERMECTIN
- 2014SOOLANTRABrand (NDA)
NDA 206255 · GALDERMA LABS LP
- 2012SKLICEBrand (NDA)
NDA 202736 · ARBOR PHARMS LLC
- 1998STROMECTOLBrand (NDA)
NDA 050742 · MERCK SHARP DOHME
- 2026IVERMECTINGeneric (ANDA)
ANDA 218509 · AJANTA PHARMA LTD
- 2026IVERMECTINGeneric (ANDA)
ANDA 216808 · E5 PHARMA
- 2026IVERMECTINGeneric (ANDA)
ANDA 216863 · ZYDUS LIFESCIENCES
- 2025IVERMECTINGeneric (ANDA)
ANDA 218805 · EPIC PHARMA LLC
- 2025IVERMECTINGeneric (ANDA)
ANDA 215922 · RUBICON RESEARCH
- 2024IVERMECTINGeneric (ANDA)
ANDA 218324 · SENORES PHARMS
- 2022IVERMECTINGeneric (ANDA)
ANDA 215210 · ZYDUS LIFESCIENCES
- 2022IVERMECTINGeneric (ANDA)
ANDA 212485 · TEVA PHARMS USA
- 2020IVERMECTINGeneric (ANDA)
ANDA 210720 · TARO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
